Proto Labs, Inc.
PRLB
$75.44
$2.803.86%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 546.26M | 533.13M | 518.38M | 508.64M | 499.21M |
| Total Other Revenue | -- | 234.00K | 440.00K | 721.00K | 830.00K |
| Total Revenue | 546.26M | 533.13M | 518.38M | 508.64M | 499.21M |
| Cost of Revenue | 301.23M | 295.99M | 289.66M | 283.98M | 277.77M |
| Gross Profit | 245.03M | 237.14M | 228.72M | 224.66M | 221.43M |
| SG&A Expenses | 169.32M | 168.13M | 163.99M | 161.13M | 157.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 513.29M | 506.93M | 495.83M | 486.36M | 476.04M |
| Operating Income | 32.97M | 26.20M | 22.55M | 22.28M | 23.16M |
| Income Before Tax | 36.39M | 31.06M | 22.63M | 22.25M | 22.93M |
| Income Tax Expenses | 10.64M | 9.82M | 7.79M | 7.43M | 8.01M |
| Earnings from Continuing Operations | 25.75 | 21.24 | 14.84 | 14.81 | 14.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.75M | 21.24M | 14.84M | 14.81M | 14.92M |
| EBIT | 32.97M | 26.20M | 22.55M | 22.28M | 23.16M |
| EBITDA | 66.49M | 60.34M | 57.40M | 57.61M | 58.89M |
| EPS Basic | 1.08 | 0.89 | 0.62 | 0.61 | 0.60 |
| Normalized Basic EPS | 1.02 | 0.84 | 0.74 | 0.71 | 0.72 |
| EPS Diluted | 1.06 | 0.88 | 0.61 | 0.60 | 0.60 |
| Normalized Diluted EPS | 1.01 | 0.83 | 0.73 | 0.71 | 0.72 |
| Average Basic Shares Outstanding | 95.39M | 95.69M | 96.40M | 97.49M | 98.90M |
| Average Diluted Shares Outstanding | 96.75M | 96.90M | 97.20M | 98.03M | 99.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |